工程设计的CAR-NKT细胞外囊泡抑制瘤进展,增强抗瘤免疫力

Xiaopei Hao1,2, Chengming Qu3,4, Yanzhao Zhou5

  • 1Department of Hepatobiliary and Pancreatic Surgery, The Affiliated Cancer Hospital of Zhengzhou University & Henan Cancer Hospital, Zhengzhou, 450008, China.

概括

CAR-NKT细胞疗法显示出有前途,但有毒性问题. 新的CARTM4SF1 - 细胞外囊泡 (EVs) 提供了优越的抗瘤效果,降低了毒性,促进了癌症免疫治疗.